TY - JOUR
T1 - Effect of sleeve gastrectomy on type 2 diabetes as an alternative treatment modality to Roux-en-Y gastric bypass
T2 - Systemic review and meta-analysis
AU - Cho, Jun Min
AU - Kim, Hyun Jung
AU - Menzo, Emanuele Lo
AU - Park, Sungsoo
AU - Szomstein, Samuel
AU - Rosenthal, Raul J.
N1 - Publisher Copyright:
© 2015 American Society for Bariatric Surgery.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2015/11/1
Y1 - 2015/11/1
N2 - Background Until recently, Roux-en-Y gastric bypass (RYGB) was the most frequently performed procedure in bariatric surgery. In the last decade, sleeve gastrectomy (SG) has emerged as a more popular, simpler, and less morbid form of bariatric surgery. Objectives This study compares the efficacy of SG and RYGB for the treatment of type 2 diabetes mellitus (T2D). Setting Systemic review and meta-analysis. Methods MEDLINE, EMBASE, and the Cochrane Library were searched for entries up to December 2013. Search terms included "Sleeve gastrectomy," "Gastric bypass," and "Type 2 diabetes mellitus." The chosen articles described both "Sleeve gastrectomy" and "Gastric bypass" and included over 1 year of follow-up data. Data analysis was performed with Review Manager 5.2 and SPSS version 20. Results The data set is comprised of 3 retrospective clinical studies, 6 prospective clinical studies, and 2 randomized controlled trials (RCTs), which involved 429 patients in the SG group and 428 patients in the RYGB group. In nonrandomized clinical studies, SG displayed similar efficacy in remission of T2D compared with the standard RYGB. In the RCTs, SG had a lower effect than that of RYGB. T2D remission was not correlated with the percent of excess weight loss for either procedure. Conclusions Based on the current evidence, SG has a similar effect on T2D remission as RYGB.
AB - Background Until recently, Roux-en-Y gastric bypass (RYGB) was the most frequently performed procedure in bariatric surgery. In the last decade, sleeve gastrectomy (SG) has emerged as a more popular, simpler, and less morbid form of bariatric surgery. Objectives This study compares the efficacy of SG and RYGB for the treatment of type 2 diabetes mellitus (T2D). Setting Systemic review and meta-analysis. Methods MEDLINE, EMBASE, and the Cochrane Library were searched for entries up to December 2013. Search terms included "Sleeve gastrectomy," "Gastric bypass," and "Type 2 diabetes mellitus." The chosen articles described both "Sleeve gastrectomy" and "Gastric bypass" and included over 1 year of follow-up data. Data analysis was performed with Review Manager 5.2 and SPSS version 20. Results The data set is comprised of 3 retrospective clinical studies, 6 prospective clinical studies, and 2 randomized controlled trials (RCTs), which involved 429 patients in the SG group and 428 patients in the RYGB group. In nonrandomized clinical studies, SG displayed similar efficacy in remission of T2D compared with the standard RYGB. In the RCTs, SG had a lower effect than that of RYGB. T2D remission was not correlated with the percent of excess weight loss for either procedure. Conclusions Based on the current evidence, SG has a similar effect on T2D remission as RYGB.
KW - Bariatric surgery
KW - Diabetes
KW - Gastric bypass
KW - Meta-analysis
KW - Remission
KW - Sleeve gastrectomy
KW - Systemic review
UR - http://www.scopus.com/inward/record.url?scp=84940203785&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84940203785&partnerID=8YFLogxK
U2 - 10.1016/j.soard.2015.03.001
DO - 10.1016/j.soard.2015.03.001
M3 - Article
C2 - 26071847
AN - SCOPUS:84940203785
SN - 1550-7289
VL - 11
SP - 1273
EP - 1280
JO - Surgery for Obesity and Related Diseases
JF - Surgery for Obesity and Related Diseases
IS - 6
ER -